The biopharmaceuticals manufacturing consumables testing market is growing, driven by demand for validated products, while US tariffs are simultaneously escalating costs for critical testing consumables.

1 report, 0 independent Updated Jul 3

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Thermo Fisher Scientific (Netherlands)Danaher Corporation Merck KGaA

Keep exploring

Part of

Danaher Corporation reported increased demand for consumables from large pharmaceutical customers in Europe and Southeast Asia. All 1 developments

The entities involved

Thermo Fisher Scientific (Netherlands)
Nothing else this week.
Danaher Corporation
American conglomerate
- Sidharth Kapileshwar joins MaxCyte as Chief Corporate Development Officer after leaving Danaher Corporation.Wed 14:03
- MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.Tue 20:16
Merck KGaA
German multinational science and technology company
- MSD, which operates as Merck & Co. in the US and Canada, has appointed Vidhya as Associate Vice President.Mon 12:02
- Merck KGaA filed required 13F reports with the Securities and Exchange Commission regarding institutional holdings on June 15, 2026.Mon 02:05

Coverage

Newest first; wire copies grouped

Jul 3Unknown outlet